The Lynx Group
Cholangiocarcinoma News

Personalized Medicine

June/July 2021, Vol 2, No 2 — July 28, 2021
Personalized medicine has expanded the treatment options for patients with cholangiocarcinoma (CCA). At the 2021 Annual Meeting of the Cholangiocarcinoma Foundation (CCF), Ghassan K. Abou-Alfa, MD, MBA, Professor of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, discussed recent developments in personalized therapies, highlighting genomic alterations that are informing the new therapies for patients with CCA.
Read More


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: